LAURA HAY: Open Payments
NPI 1891935268 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,259 in 74 payments from 15 companies in 2025. Trend: 2023 $1,540 · 2024 $2,570 · 2025 $2,259
Food & beverage: $2,244Education: $15
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $366 |
| Novartis Pharmaceuticals Corporation | 16 | $289 |
| Janssen Biotech, Inc. | 12 | $248 |
| ABBVIE INC. | 12 | $228 |
| Amgen Inc. | 3 | $197 |
| UCB, Inc. | 7 | $188 |
| LEO Pharma Inc. | 3 | $144 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $144 |
| Incyte Corporation | 1 | $125 |
| PFIZER INC. | 3 | $93 |
Products named: TREMFYA, COSENTYX, DUPIXENT, Bimzelx, OTEZLA, SKYRIZI, Opzelura, ANZUPGO.
Industry payments across NV — which companies pay providers there.
